Social & Contextual Impact on Children Undergoing Liver Transplantation
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Sep 10, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how social factors, like income and support systems, affect children undergoing liver transplantation. Researchers want to understand how these factors can influence health outcomes, such as how well the transplant works and how well families follow medical advice after the surgery. To do this, caregivers of children being transplanted will fill out surveys and participate in interviews. These surveys will collect information about their financial situation, access to healthcare, and social connections. The interviews will help identify any challenges these families face and explore ways to improve support for them.
To be part of this study, caregivers must have a child under 18 who is scheduled for a liver transplant and must agree to participate. Families will be excluded if they cannot complete the survey, if the child is in foster care, or if they don't speak English or Spanish. Health care providers involved in the care of these children will also be interviewed to better understand barriers they face in addressing social needs. Overall, this study aims to find ways to improve care for children undergoing liver transplantation by considering their social circumstances.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Caregivers/parents of children with the following criteria will be approached for inclusion in this study:
- • Children \<18 years of age at the time of transplant
- • Undergoing liver transplantation
- • Guardian's consent, child assent (in accordance with each institution's IRB policies)
- • Consents to enrollment in SPLIT
- Exclusion Criteria:
- Caregivers/parents of children undergoing liver transplantation will be excluded it:
- • Caregiver unwilling or unable to complete the survey
- • Child is a ward of the state (e.g., foster care) since present circumstances may not be reflective of child's past or future circumstances
- • Non-English, non-Spanish speakers
- • Non-US residents
- • Declined participation in SPLIT
- Inclusion Criteria for Interview Portion of the Study:
- • Participants who have completed the questionnaire OR
- • Medical team member involved in the care of children undergoing liver transplant (e.g., physician, nurse, social worker)
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Cincinnati, Ohio, United States
Los Angeles, California, United States
Seattle, Washington, United States
Pittsburgh, Pennsylvania, United States
Palo Alto, California, United States
Dallas, Texas, United States
Atlanta, Georgia, United States
San Francisco, California, United States
Patients applied
Trial Officials
Sharad Wadhwani, MD, MPH
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials